PT Esa Medika Mandiri Tbk (IDX:EMMI)

PT Esa Medika Mandiri Tbk Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	34,132	11,009	939.42
Depreciation & Amortization	20,938	22,458	19,271
Other Operating Activities	-62,567	38,061	-74,616
Operating Cash Flow	-7,497	71,527	-54,405
Capital Expenditures	-26,616	-20,312	-39,537
Sale of Property, Plant & Equipment	702.7	1,357	138.29
Investment in Securities	-	-	-3,000
Investing Cash Flow	-25,913	-18,955	-42,398
Long-Term Debt Issued	189,616	195,651	76,491
Long-Term Debt Repaid	-250,887	-90,532	-4,071
Net Debt Issued (Repaid)	-61,271	105,119	72,420
Other Financing Activities	34,059	-78,084	-
Financing Cash Flow	-27,212	27,035	72,420
Miscellaneous Cash Flow Adjustments	-	-34.2	164.36
Net Cash Flow	-60,623	79,573	-24,218
Free Cash Flow	-34,113	51,215	-93,942
Free Cash Flow Margin	-7.50%	13.30%	-54.31%
Free Cash Flow Per Share	-27.96	41.98	-77.00
Cash Income Tax Paid	-3,541	6,181	-3,701
Levered Free Cash Flow	-28,138	-8,727	-
Unlevered Free Cash Flow	-9,114	9,719	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 13, 2026

Data Sources Report a data error